Fluctuations in blood lipid levels during furosemide therapy: A randomized, double-blind, placebo-controlled crossover study

Archives of Internal Medicine

Volumn 158, Issue 13, 1998, Pages 1461-1463

  Campbell, Norman ^a   Brant, Rollin ^a   Stalts, Helga ^a   Stone, James ^a   Mahallati, Houman ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FUROSEMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY RISK; CROSSOVER PROCEDURE; DIURESIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOVOLEMIA; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; APOLIPOPROTEINS; CHOLESTEROL; CHRONIC DISEASE; CROSS-OVER STUDIES; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0032527689     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.13.1461     Document Type: Article

References (17)

1. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335: 490-498.
2. Johnstone DE, Abdulla A, Arnold JM, et al. Diagnosis and management of heart failure. Can J Clin Pharmacol. 1994;1:105-123.
3. Simonsen LL. What are pharmacists dispensing most often? top 200 drugs of 1992. Pharm Times. 1993;29-39.
4. Campbell NR, Wickert WA, Shumak SL. Frusemide causes acute increases in lipid concentrations. Br J Clin Pharmacol. 1993;36:607-609.
5. Campbell NR, Wickert W, Magner P, Shumak SL. Dehydration during fasting increases serum lipids and lipoproteins. Med Clin Exp. 1994;17:570-576.
6. Campbell NR, Purchase LH, Longerich LL, Gault MH. Prediction of reduction in predialysis concentrations due to interdialysis weight gain. Nephron. 1995;71:65-74.
7. Ames RP, Hill P. Antihypertensive therapy and the risk of coronary heart disease. J Cardiovasc Pharmacol. 1982;4(suppl 2):S206-S212.
8. Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins, I: diuretics. Drugs. 1986;32:260-278.
9. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 7th ed. Boston, Mass: Little Brown & Co Inc: 1973.
10. Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC. "Water diuresis" produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest. 1951;30:862-868.
11. Dawson KG, McKenzie JK, Ross SA, Chiasson J, Hamet P. Report of the Canadian Hypertension Society Consensus Conference: hypertension and diabetes. CMAJ. 1993;149:821-826.
12. National cholesterol education program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult treatment panel II. Circulation. 1994;89:1333-1432.
13. Hammarlund-Udenaes M, Benet LZ. Furosemide pharmacokinetics and pharmacodynamics in health and disease: an update. J Pharmacokinet Biopharm. 1989; 17:1-46.
14. Ponto LL, Schoenwald RD. Furosemide (frusemide): a pharmacokinetic/ pharmacodynamic review (part I). Clin Pharmacokinet. 1990;18:381-408.
15. Ponto LL, Schoenwald RD. Furosemide (frusemide): a pharmacokinetic/ pharmacodynamic review (part II). Clin Pharmacokinet 1990;18:460-471.
16. Joos C, Kewitz H, Reinhold-Kourniati D. Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmacol. 1980;17:251-257.
17. Gluck Z, Baumgartner B. Weidmann P, et al. Increased ratio between serum b and a lipoproteins during diuretic therapy. Clin Sci Mol Med. 1978;55:325s-328s.